Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Tamara Ghanem

- PMLiVE

Optimism on Orkambi in England as talks to resume

Scotland's deal puts pressure on NHS England and NICE

AstraZeneca AZ

AZ signs $20m deal with Seres for microbiome project

Shares in Seres shot up 25% after the deal was announced

- PMLiVE

23andMe to offer type 2 diabetes testing kit

New report is powered by data from the company’s customers

- PMLiVE

The Communiqué Awards: what are judges looking for?

Judges in the Communiqué Awards reveal how to bring creativity and strategic thinking together

Cuttsy+Cuttsy named one of the Best Places to Work 2019 by Campaign

11 March 2019—Cuttsy+Cuttsy are honoured and extremely proud to be named one of the 50 Best Places to Work in 2019 by Campaign. The results were announced on 6th March...

Cuttsy + Cuttsy

- PMLiVE

Tecentriq gains first IO approval in triple negative breast cancer

A coup for Roche in IO field dominated by Keytruda

- PMLiVE

Shionogi planning HQ move from UK

Brexit understood to be main reason for switch

- PMLiVE

UK Biobank generates “largest open access resource of exome data”

Around 50,000 de-identifed genetic profiles available for research

- PMLiVE

Pegasus expands Pharma team with senior hires

Five new recruits support further growth of the Pharma & Life Sciences team

Inizio

- PMLiVE

Takeda’s Entyvio tops Humira in ulcerative colitis

Entyvio is important for post-merger Takeda

“Brexit has been a catalyst for UK clinical research… it’s turbocharged change”

The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?

- PMLiVE

GSK, J&J say monthly injection keeps HIV controlled

The once every four-week treatment could free those from taking daily pills

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links